These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38976830)

  • 1. Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection.
    Li Y; Liu B; Zhou X; Yang H; Han T; Hong Y; Wang C; Huang M; Yan S; Li S; Li J; Liu Y; Zhang E; Ni Y; Shen N; Chen W; Huang YS; Wu N
    JCO Precis Oncol; 2024 Jun; 8():e2400111. PubMed ID: 38976830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
    Liu J; Dai L; Wang Q; Li C; Liu Z; Gong T; Xu H; Jia Z; Sun W; Wang X; Lu M; Shang T; Zhao N; Cai J; Li Z; Chen H; Su J; Liu Z
    Nat Commun; 2024 May; 15(1):3700. PubMed ID: 38697989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
    Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
    [No Abstract]   [Full Text] [Related]  

  • 4. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
    Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
    Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma.
    Bian Y; Gao Y; Lu C; Tian B; Xin L; Lin H; Zhang Y; Zhang X; Zhou S; Wan K; Zhou J; Li Z; Chen H; Wang L
    Chin Med J (Engl); 2024 Jul; 137(14):1724-1735. PubMed ID: 37650127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
    Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
    Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma.
    Jiao Z; Zhang X; Xuan Y; Shi X; Zhang Z; Yu A; Li N; Yang S; He X; Zhao G; Yang R; Chen J; Wu X; Bao H; Wang F; Ren W; Liang H; Chen Q; Wang T
    Cell Rep Med; 2024 Aug; 5(8):101664. PubMed ID: 39089259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control Study.
    Han Y; Wei J; Wang W; Gao R; Shen N; Song X; Ni Y; Li Y; Xu LD; Chen W; Li X
    JMIR Res Protoc; 2023 Sep; 12():e48247. PubMed ID: 37728978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome.
    Li S; Li W; Liu B; Krysan K; Dubinett SM
    Cancer Res Commun; 2024 Jul; 4(7):1738-1747. PubMed ID: 38856716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
    Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
    Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nasrollahzadeh D; Roshandel G; Delhomme TM; Avogbe PH; Foll M; Saidi F; Poustchi H; Sotoudeh M; Malekzadeh R; Brennan P; Mckay J; Hainaut P; Abedi-Ardekani B
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
    Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
    BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.
    Kim SY; Jeong S; Lee W; Jeon Y; Kim YJ; Park S; Lee D; Go D; Song SH; Lee S; Woo HG; Yoon JK; Park YS; Kim YT; Lee SH; Kim KH; Lim Y; Kim JS; Kim HP; Bang D; Kim TY
    Exp Mol Med; 2023 Nov; 55(11):2445-2460. PubMed ID: 37907748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Hsieh CC; Hsu HS; Chang SC; Chen YJ
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
    Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
    Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.